Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shitiz Sriwastava

Concepts (102)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
10
2025
77
6.840
Why?
Leukoencephalopathy, Progressive Multifocal
5
2022
16
3.510
Why?
JC Virus
4
2022
12
2.840
Why?
Myelitis, Transverse
3
2021
8
2.030
Why?
Brain Diseases
3
2021
85
1.790
Why?
Neuromyelitis Optica
3
2024
7
1.770
Why?
Central Nervous System Diseases
2
2022
28
1.380
Why?
Nervous System Diseases
2
2023
93
1.330
Why?
Peripheral Nervous System Diseases
2
2021
60
1.320
Why?
Autoantibodies
3
2023
120
1.010
Why?
Myasthenia Gravis
3
2021
18
0.950
Why?
Humans
31
2025
53246
0.860
Why?
Receptors, Cholinergic
2
2021
14
0.850
Why?
Cost of Illness
1
2024
121
0.820
Why?
Multiple Sclerosis, Chronic Progressive
1
2024
6
0.820
Why?
Paraneoplastic Syndromes, Nervous System
1
2023
5
0.800
Why?
Colitis
1
2023
49
0.740
Why?
Neoplasms
2
2023
1335
0.740
Why?
Optic Neuritis
1
2022
21
0.730
Why?
Acquired Immunodeficiency Syndrome
1
2022
53
0.720
Why?
Vaccination
2
2021
310
0.710
Why?
Herpes Zoster
1
2022
16
0.710
Why?
Myositis
1
2021
20
0.700
Why?
Immunologic Factors
1
2022
117
0.690
Why?
Cerebrospinal Fluid
1
2021
29
0.690
Why?
Antirheumatic Agents
1
2021
40
0.680
Why?
Spinal Cord
2
2022
130
0.680
Why?
Vertigo
1
2021
17
0.670
Why?
Primary Dysautonomias
1
2021
3
0.670
Why?
Diplopia
1
2021
20
0.670
Why?
Leukocytosis
1
2021
11
0.660
Why?
Headache
1
2021
75
0.660
Why?
Guillain-Barre Syndrome
1
2020
13
0.660
Why?
Male
14
2024
27444
0.570
Why?
Lipoid Proteinosis of Urbach and Wiethe
1
2018
1
0.570
Why?
Calcinosis
1
2018
53
0.540
Why?
HIV Infections
1
2022
402
0.530
Why?
Neuroimaging
3
2023
95
0.520
Why?
Antineoplastic Agents
2
2023
1232
0.510
Why?
Coronavirus Infections
1
2020
188
0.510
Why?
Magnetic Resonance Imaging
4
2025
1587
0.450
Why?
Myelin-Oligodendrocyte Glycoprotein
2
2022
8
0.360
Why?
West Virginia
2
2022
6
0.350
Why?
Middle Aged
6
2024
13422
0.330
Why?
Female
8
2024
28792
0.310
Why?
Adult
6
2024
14541
0.310
Why?
Anti-Inflammatory Agents
2
2021
164
0.300
Why?
Immunotherapy
2
2022
266
0.300
Why?
Antibodies, Monoclonal
2
2023
477
0.290
Why?
Hospitalization
2
2024
749
0.280
Why?
Aquaporin 4
2
2022
8
0.230
Why?
Young Adult
2
2024
4514
0.190
Why?
Aged
3
2021
10430
0.190
Why?
Brain
2
2021
1353
0.190
Why?
Recurrence
1
2024
694
0.190
Why?
B-Lymphocytes
1
2023
178
0.180
Why?
Simplexvirus
1
2022
17
0.180
Why?
Central Nervous System
1
2022
76
0.180
Why?
Herpesvirus 3, Human
1
2022
32
0.180
Why?
Peripheral Nervous System
1
2021
16
0.180
Why?
Endemic Diseases
1
2021
26
0.170
Why?
Tuberous Sclerosis
1
2022
38
0.170
Why?
Valsalva Maneuver
1
2021
10
0.170
Why?
Viral Load
1
2021
83
0.170
Why?
Meningitis
1
2021
25
0.170
Why?
Bromocriptine
1
2021
5
0.170
Why?
Disability Evaluation
1
2021
92
0.170
Why?
Dopamine Agonists
1
2021
10
0.170
Why?
Universities
1
2022
186
0.170
Why?
Methylprednisolone
1
2021
41
0.170
Why?
Neurologic Examination
1
2021
75
0.170
Why?
Retrospective Studies
2
2024
6821
0.160
Why?
Prednisone
1
2021
101
0.160
Why?
Toxoplasmosis, Cerebral
1
2020
3
0.160
Why?
Immunocompromised Host
1
2021
124
0.160
Why?
Neural Conduction
1
2020
34
0.160
Why?
Cyclophosphamide
1
2021
178
0.160
Why?
Cohort Studies
1
2024
1557
0.160
Why?
China
1
2020
135
0.160
Why?
Acute Disease
1
2021
393
0.160
Why?
Lymphoma
1
2020
71
0.150
Why?
Radiopharmaceuticals
1
2020
198
0.150
Why?
Fluorodeoxyglucose F18
1
2020
182
0.150
Why?
Immunosuppressive Agents
1
2021
253
0.150
Why?
Biopsy
1
2021
600
0.150
Why?
Comorbidity
1
2021
638
0.140
Why?
Lactams, Macrocyclic
1
2018
19
0.140
Why?
Disease Progression
1
2021
880
0.140
Why?
Age Factors
1
2021
1136
0.140
Why?
Severity of Illness Index
1
2021
1049
0.130
Why?
Brain Neoplasms
1
2020
319
0.120
Why?
Prognosis
1
2021
2118
0.120
Why?
Pandemics
1
2020
595
0.120
Why?
Treatment Outcome
1
2021
5597
0.080
Why?
Animals
1
2024
13528
0.070
Why?
Child
1
2018
7384
0.060
Why?
Lactams
1
2018
28
0.030
Why?
Aminopyridines
1
2018
19
0.030
Why?
Diagnosis, Differential
1
2020
1038
0.030
Why?
Pyrazoles
1
2018
123
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2018
175
0.030
Why?
Lung Neoplasms
1
2018
645
0.020
Why?
Sriwastava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description